Cargando…

Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men

Introduction & Objective: Exogenous testosterone (T) replacement therapy (TRT) is typically long-acting and can potentially cause infertility in a majority of men due to suppression of HPG axis. Intratesticular testosterone is vital for spermatogenesis and can be reliably evaluated with serum 17...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kresch, Eliyahu, Gonzalez, Daniel, Ory, Jesse, Nackeeran, Sirpi, Blachman-Braun, Ruben, Molina, Manuel, Ramasamy, Ranjith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089654/ http://dx.doi.org/10.1210/jendso/bvab048.1543

Ejemplares similares

Impact of Testosterone Therapy on Hematocrit and Polycythemia: Evaluation of Data From Two Ongoing Open-Label Randomized Single-Center Clinical Trials
por: Gonzalez, Daniel, et al.
Publicado: (2021)

Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
por: Kresch, Eliyahu, et al.
Publicado: (2023)

Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials
por: Diaz, Parris, et al.
Publicado: (2023)

Effect of microsurgical varicocelectomy on semen parameters, serum, and intratesticular testosterone levels
por: Lima, Thiago Fernandes Negris, et al.
Publicado: (2020)

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
por: Delgado, Jessica, et al.
Publicado: (2022)

A Review of Testosterone Pellets in the Treatment of Hypogonadism
por: McCullough, Andrew
Publicado: (2014)

Short-Acting Testosterone: More Physiologic?
por: Westfield, Gerwin, et al.
Publicado: (2020)

SUN-220 The Effect of Testosterone Nasal Gel on Reproductive Hormones and Semen Parameters
por: Masterson, Thomas, et al.
Publicado: (2019)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

SAT-037 Effect of Weight on Serum Testosterone with Subcutaneous Testosterone Enanthate in Men with Testosterone Deficiency
por: Bhattacharya, Rajib, et al.
Publicado: (2020)

Testosterone Therapy in Advanced Prostate Cancer
por: Chedrawe, Emily, et al.
Publicado: (2022)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

OR25-06 The Effect of Testosterone Replacement Therapy on NAFLD in Elderly Hypogonadal Men
por: Seung Lee, Hae, et al.
Publicado: (2023)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
por: Dadhich, Pranav, et al.
Publicado: (2017)

SAT-LB6 First Human Trial of an Oral Native Testosterone Shows Physiological Levels of Testosterone and Dht in Both Fasted and Fed State in Hypogonadal Men
por: Newell-Price, John D C, et al.
Publicado: (2020)

SUN-234 Effect of Testosterone Undecanoate on Metabolic Syndrome Parameters in a Cohort of Hypogonadism
por: Yadav, Subhash Chandra, et al.
Publicado: (2019)

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy
por: Graziani, Andrea, et al.
Publicado: (2023)

SUN-237 Higher Doses of Testosterone Gel Required in Hypogonadal Men with Obesity to Achieve Therapeutic Replacement - Advice on Dose Titration
por: Mumdzic, Enis, et al.
Publicado: (2019)

Association of Leptin with Total and Free Testosterone: Results from the National Health and Nutrition Examination Surveys
por: Lima, Thiago Fernandes Negris, et al.
Publicado: (2020)

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
por: Lakshman, Kishore M, et al.
Publicado: (2009)

PMON267 Comparison Between Single Time Point Testing and 24-Hour Average Concentration of Total Testosterone in Hypogonadal Men Treated with an Oral Testosterone Undecanoate Softgel (JATENZO®)
por: Swerdloff, Ronald, et al.
Publicado: (2022)

Testosterone Therapy in Men with Advanced Prostate Cancer: Too Many Unknowns for Safe Use
por: Ory, Jesse, et al.
Publicado: (2021)

Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010)

Testosterone-Associated Dietary Pattern Predicts Low Testosterone Levels and Hypogonadism
por: Hu, Tzu-Yu, et al.
Publicado: (2018)

SUN-222 Testosterone Treatment in Men with Classical vs. Functional Hypogonadism: A 9-Year Registry
por: Zitzmann, Michael, et al.
Publicado: (2019)

Advanced Paternal Age and Sperm DNA Fragmentation: A Systematic Review
por: Gonzalez, Daniel C., et al.
Publicado: (2022)

Pre-treatment estradiol does not predict testosterone response to clomiphene citrate
por: Masterson, John M., et al.
Publicado: (2020)

SUN-229 The Role of Testosterone in Spermatogenesis: Lessons from Proteome Profiling of Human Spermatozoa in Testosterone Deficiency
por: Grande, Giuseppe, et al.
Publicado: (2019)

THU645 Comparison Of LC-MS/MS Testosterone Assays Towards Standardization Of Lower Testosterone Ranges
por: Cree, Melanie G, et al.
Publicado: (2023)

PMON258 Patient-Reported Outcomes for men with Hypogonadism and the Impact of Low Testosterone Levels: a review of measures
por: Jayasena, Channa N, et al.
Publicado: (2022)

SAT-045 Free Testosterone and Cardiometabolic Parameters in Adult Men - Comparison of Algorithms for Calculation of Serum Free Testosterone
por: Holmboe, Stine Agergaard, et al.
Publicado: (2020)

Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

Efficacy and Safety of Human Chorionic Gonadotropin Monotherapy for Men With Hypogonadal Symptoms and Normal Testosterone
por: Zucker, Isaac, et al.
Publicado: (2022)

SAT-038 Ambulatory Blood Pressure Increases in Hypogonadal Men Who Develop Increases in Hematocrit on Oral Testosterone Undecanoate
por: Dobs, Adrian Sandra, et al.
Publicado: (2020)

SAT-047 Adoption of an Age Adjusted Testosterone Reference Range Reduces Referrals to Endocrine Clinic and New Prescriptions of Testosterone
por: Dewdney, Charlotte, et al.
Publicado: (2020)

AB173. Effect of testosterone replacement therapy on lipid profile in the patients with testosterone deficiency syndrome
por: Han, Kyung-Sik, et al.
Publicado: (2014)

Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012)

SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment
por: DelConte, Anthony, et al.
Publicado: (2020)

SUN-LB043 Phase 2 Randomized Study of the Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients with Hypogonadism
por: Tishova, Yuliya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b3pmge05gn31bb0oicimmcrkq2